Remarkably, our recent studies revealed that EPCR could function as a negative regulator of cancer progression in malignant pleural mesothelioma (MPM)21 – New Small-Molecule Inhibitors Neurodegeneration and Neuropathic Pain

Remarkably, our recent studies revealed that EPCR could function as a negative regulator of cancer progression in malignant pleural mesothelioma (MPM)21. founded MPM originating from MPM cells lacking EPCR reduced the progression of tumor growth. Ad.EPCR treatment elicited recruitment of macrophages and NK cells into the tumor microenvironment and increased IFN and TNF levels in … Continue reading Remarkably, our recent studies revealed that EPCR could function as a negative regulator of cancer progression in malignant pleural mesothelioma (MPM)21